fying circulating tumor cells

负责人：

关键词：

Circulating Tumor Cells;mAbs;Glycosylation;CD45 protein

DOI：

doi:10.5061/dryad.gg0nk

摘要：

al factors for differentiate circulating tumor cells from white blood cells in human breast cancer patient samples. Only 1 cell fusion and 2 cyclic sub-cloning

Data from: High specificity in circulating tumor cell identification is required for accurate evaluation of programmed death-ligand 1

负责人：

关键词：

Circulating Tumor Cells;Non-Small Cell Lung Cancer;PD-L1;Pharmacodynamic biomarkers

DOI：

doi:10.5061/dryad.q8150

摘要：

; however, recent advances in the identification of circulating tumor cells (CTCs) may be a less invasive method to assay tumor cells for these purposes

Data from: The lncRNA H19 mediates breast cancer cell plasticity during EMT and MET plasticity by differentially sponging miR-200b/c and let-7b

负责人：

关键词：

DOI：

doi:10.5061/dryad.t5pv8

摘要：

the primary mammary tumor, the circulation, and metastatic lesions in the lung in TA2 mice and found that the long noncoding RNA (lncRNA) H19 mediated EMT

Data from: Effect of dimethyl fumarate on lymphocytes in RRMS: implications for clinical practice

负责人：

关键词：

Multiple Sclerosis;Clinical Trials

DOI：

doi:10.5061/dryad.n0cg254

摘要：

on, which also was reflected in the global reduction in numbers of circulating functional lymphocyte subsets. The relative frequencies of circulating memor

Data from: Aberrant FGFR signaling mediates resistance to CDK4/6 inhibitors in ER+ breast cancer

负责人：

关键词：

USA;Breast Cancer

DOI：

doi:10.5061/dryad.20j465p

摘要：

induced complete responses of FGFR1-amplified/ER+ patient-derived-xenografts. Next generation sequencing of circulating tumor DNA (ctDNA) in 34 patients aft